GSK recalls prescription-only versions of heartburn drug Zantac

GlaxoSmithKline is recalling prescription-only versions of its popular heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drugs, Britain's medicines watchdog said on Tuesday.